GoodRx launches market-wide Employer Direct weight loss offering for GLP-1 benefits
Key points
- GoodRx launched its Employer Direct weight loss offering market-wide
- Employers can choose which FDA-approved GLP-1 medications to include and set contribution levels
- The offering includes manufacturer employer pricing for Wegovy and Zepbound KwikPen; GoodRx is an approved administrator for Lilly Employer Connect
GoodRx announced the market-wide launch of its Employer Direct weight loss offering, letting employers choose which FDA-approved GLP-1 medications to include, set contribution levels and add clinical care. It provides manufacturer-made employer pricing for Wegovy and Zepbound KwikPen, among others. GoodRx collaborates with Novo on employer pricing and is an approved administrator for Lilly Employer Connect.
Original report: FinancialContent ↗Edited with AI assistance. Facts are based on official sources and original reports. For information only; not legal, immigration or insurance advice.